Mary Coelho
Finanzdirektor/CFO bei GAMIDA CELL LTD.
Vermögen: 55 388 $ am 30.04.2024
Aktive Positionen von Mary Coelho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FIRST WAVE BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 11.08.2021 | - |
Independent Dir/Board Member | 11.08.2021 | - | |
HOOKIPA PHARMA INC. | Direktor/Vorstandsmitglied | 03.04.2023 | - |
Independent Dir/Board Member | 03.04.2023 | - | |
GAMIDA CELL LTD. | Comptroller/Controller/Auditor | 22.05.2023 | - |
Finanzdirektor/CFO | 22.05.2023 | - | |
INOTIV, INC. | Direktor/Vorstandsmitglied | 16.10.2023 | - |
Independent Dir/Board Member | 16.10.2023 | - |
Karriereverlauf von Mary Coelho
Ehemalige bekannte Positionen von Mary Coelho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CINCOR PHARMA, INC. | Finanzdirektor/CFO | 01.11.2021 | 04.11.2022 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Finanzdirektor/CFO | 15.01.2019 | 03.11.2021 |
Investor Relations Kontakt | - | 03.11.2021 | |
Treasurer | 15.01.2019 | 03.11.2021 | |
BALCHEM CORPORATION | Finanzdirektor/CFO | 23.10.2017 | 26.10.2018 |
Treasurer | 23.10.2017 | 26.10.2018 | |
Diversey, Inc.
Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Geschäftsführer | 01.09.2017 | 01.10.2017 |
Finanzdirektor/CFO | 01.10.2014 | 01.09.2017 | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.01.2007 | 01.10.2014 |
░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Mary Coelho
School of International Service | Undergraduate Degree |
Ibmec Business School | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 12 |
Brasilien | 2 |
Operativ
Director of Finance/CFO | 5 |
Director/Board Member | 3 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 7 |
Consumer Non-Durables | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
BALCHEM CORPORATION | Consumer Non-Durables |
FIRST WAVE BIOPHARMA, INC. | Health Technology |
HOOKIPA PHARMA INC. | Health Technology |
GAMIDA CELL LTD. | Health Technology |
INOTIV, INC. | Commercial Services |
Private Unternehmen | 5 |
---|---|
Diversey, Inc.
Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Consumer Non-Durables |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Mars, Inc.
Mars, Inc. Food: Specialty/CandyConsumer Non-Durables Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA. | Consumer Non-Durables |
CinCor Pharma, Inc.
CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Mary Coelho
- Erfahrung